European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies

Multiple practice changing studies were presented at the 2019 ESMO Congress in Barcelona, Spain. The ovarian cancer studies presented at the Presidential session will likely refine and redefine the initial treatment of ovarian cancer. Other compelling trial data in ovarian, uterine and cervical canc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2020-02, Vol.156 (2), p.265-270
Hauptverfasser:	Herzog, Thomas J., Secord, Angeles Alvarez, Coleman, Robert L., Naumann, R. Wendel
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trials, Phase III as Topic Female Genital Neoplasms, Female - drug therapy Genital Neoplasms, Female - surgery Genital Neoplasms, Female - therapy Humans Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Multiple practice changing studies were presented at the 2019 ESMO Congress in Barcelona, Spain. The ovarian cancer studies presented at the Presidential session will likely refine and redefine the initial treatment of ovarian cancer. Other compelling trial data in ovarian, uterine and cervical cancer were also unveiled. The key oral abstracts from this meeting are summarized in this meeting report.
ISSN:	0090-8258 1095-6859
DOI:	10.1016/j.ygyno.2019.11.010